Physician

Patrick J. Eulitt, M.D.

According to 2025 Medicare claims, Patrick Eulitt, M.D. (NPI: 1447677489) practices medical oncology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Arapahoe, CO. This provider's primary affiliated billing organization is ROCKY MOUNTAIN CANCER CENTERS LLP (NPI: 1518941186; TIN: 841457488) and primary practice location at 80124-5521.

Eulitt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 669 traditional Medicare patients, billed 145,514 HCPCS/CPT codes, and received $3,503,914 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 700 prescription claims across 115 beneficiaries totaling $998,700 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 42 claims. Open Payments data shows 19 records totaling $585,356. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $14,225 to $998,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	344	87,797	$1,988,436
2021	571	167,237	$3,445,053
2022	656	166,065	$3,868,076
2023	675	186,527	$4,154,737
2024	669	145,514	$3,503,914

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	43	181	$14,225
2016	61	312	$15,938
2017	49	287	$33,935
2018	26	54	$5,248
2019	26	58	$10,907
2020	57	189	$63,352
2021	63	460	$406,763
2022	87	624	$426,716
2023	91	606	$429,463
2024	115	700	$998,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$1,665
2022	N/R	36	$3,266
2023	N/R	42	$4,159
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	209	229	$1,247
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	180	199	$74
80053	Blood test, comprehensive group of blood chemicals	128	383	$10
36415	Insertion of needle into vein for collection of blood sample	120	279	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	126	408	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	21	630	$283,481
Brukinsa	Zanubrutinib	12	360	$180,560
Eliquis	Apixaban	94	4,036	$78,374
Xarelto	Rivaroxaban	12	610	$11,355
Abiraterone Acetate	Abiraterone Acetate	28	840	$4,349

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	19	$585,356	Aadi Bioscience, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick J. Eulitt, M.D.?

Tedicare shows public-source Medicare data for Patrick J. Eulitt, M.D. (NPI 1447677489), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick J. Eulitt, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patrick J. Eulitt, M.D.?

Patrick J. Eulitt, M.D. is linked to ROCKY MOUNTAIN CANCER CENTERS LLP (billing NPI 1518941186) in the available physician profile data.

Does Patrick J. Eulitt, M.D. have Open Payments data?

Patrick J. Eulitt, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.